• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sainik Finance & Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
530265
INE584B01013
44.375
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
9.92
41.34
EPS(TTM)
Face Value()
Div & Yield %
3.83
10
0
 

Glenmark Pharmaceuticals consolidated net profit rises 6381.94% in the March 2026 quarter
May 30,2026
Net profit of Glenmark Pharmaceuticals rose 6381.94% to Rs 301.41 crore in the quarter ended March 2026 as against Rs 4.65 crore during the previous quarter ended March 2025. Sales rose 16.77% to Rs 3760.28 crore in the quarter ended March 2026 as against Rs 3220.13 crore during the previous quarter ended March 2025.

For the full year,net profit rose 30.06% to Rs 1361.85 crore in the year ended March 2026 as against Rs 1047.10 crore during the previous year ended March 2025. Sales rose 27.12% to Rs 16711.40 crore in the year ended March 2026 as against Rs 13145.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3760.283220.13 17 16711.4013145.84 27
OPM %20.2817.42 -27.3617.89 -
PBDT909.08506.00 80 4824.312258.04 114
PBT761.17380.79 100 4250.831772.03 140
NP301.414.65 6382 1361.851047.10 30